Bath & Body Works, Inc. BBWI
16.45
(0.35)
(2.08%)
as of 25 Sep
- Market cap
- $3.4B
- P/E
- 4.3×
Follow BBWI
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
7.53 | 7.06 | 5.46 | 5.24 |
P/S ratio |
0.68 | 0.63 | 0.54 | 0.56 | |
P/FCF ratio |
5.25 | 5.29 | 4.22 | 3.86 | |
P/Operating CF |
62.73 | 5.27 | 16.01 | 56.17 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.22 | 1.04 | 0.96 | 0.95 | |
EV/EBITDA |
6.13 | 5.48 | 4.99 | 4.72 | |
EV/Operating CF |
7.62 | 6.86 | 6.03 | 5.39 | |
EV/FCF |
9.41 | 8.66 | 7.54 | 6.55 | |
Quick Ratio |
0.26 | 0.71 | 0.67 | 0.56 | |
Current Ratio |
1.21 | 1.27 | 1.38 | 1.20 | |
Net Debt/EBITDA |
16.31 | 4.44 | 9.57 | 10.25 | |
Debt/Assets |
77.97% | 76.78% | 72.80% | 70.09% | |
Debt/Equity |
(2.44) | (3.04) | (3.19) | (3.43) | |
Asset Turnover |
1.47 | 1.47 | 1.47 | 1.45 | |
Operating CF/Net income |
1.04 | 2.18 | 1.33 | 0.61 | |
Capex/Depreciation |
(1.14) | (1.00) | (0.67) | (0.83) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
31.18% | 23.72% | 25.83% | 31.44% | |
Intangible Assets out of Total Assets |
0.16 | 0.16 | 0.16 | 0.15 | |
Share Based Compensation of Revenue |
0.44% | 0.22% | 0.58% | 0.13% | |
Graham Net Nets |
(0.94) | (0.94) | (1.07) | (1.03) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
13.28% | 14.16% | 18.31% | 19.09% | |
Free Cash Flow Yield |
19.03% | 18.89% | 23.70% | 25.91% | |
Revenue per Share |
7.78 | 13.10 | 6.86 | 7.53 | |
Operating CF per Share |
0.39 | 4.22 | 1.21 | 0.36 | |
Capex per Share |
(0.35) | (0.30) | (0.20) | (0.24) | |
Free Cash Flow per Share |
0.04 | 3.91 | 1.01 | 0.11 | |
Cash per Share |
1.15 | 4.58 | 4.08 | 3.95 | |
Shareholders Equity per Share |
(7.77) | (6.15) | (5.63) | (5.24) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(7.77) | (6.15) | (5.63) | (5.24) | |
Free Cash Flow |
8.00 | 814.00 | 203.00 | 23.00 | |
Working Capital |
328.00 | 428.00 | 522.00 | 343.00 | |
Capital Expenditures |
(72.00) | (63.00) | (41.00) | (49.00) | |
Net Current Asset Value |
(4,700.00) | (4,329.00) | (4,195.00) | (4,160.00) | |
EV/EBIT |
7.46 | 6.72 | 6.08 | 5.69 | |
Capex to Sales |
0.05 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
4.83% | 14.79% | 13.28% | 7.79% | |
Price to Operating Income |
4.16 | 4.11 | 3.40 | 3.35 | |
| Other line items | |||||
Average Receivables |
184.50 | 192.50 | 100.50 | 142.50 | |
Average Payables |
645.50 | 401.50 | 504.50 | 621.50 | |
Average Inventory |
1,214.50 | 716.50 | 825.50 | 930.00 | |
Average Assets |
4,986.50 | 4,970.50 | 4,922.00 | 4,985.00 | |
Average Common Equity |
(1,670.00) | (1,331.00) | (1,290.50) | (1,300.50) |
Columns are period end dates